Form 8-K - Current report:
SEC Accession No. 0001193125-22-044450
Filing Date
2022-02-16
Accepted
2022-02-16 17:03:18
Documents
46
Period of Report
2022-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d253489d8k.htm   iXBRL 8-K 25498
2 EX-99.1 d253489dex991.htm EX-99.1 26634
6 GRAPHIC g253489ex99_1p10g1.jpg GRAPHIC 305614
7 GRAPHIC g253489ex99_1p11g1.jpg GRAPHIC 267780
8 GRAPHIC g253489ex99_1p12g1.jpg GRAPHIC 249041
9 GRAPHIC g253489ex99_1p13g1.jpg GRAPHIC 254030
10 GRAPHIC g253489ex99_1p14g1.jpg GRAPHIC 294982
11 GRAPHIC g253489ex99_1p15g1.jpg GRAPHIC 295174
12 GRAPHIC g253489ex99_1p16g1.jpg GRAPHIC 278199
13 GRAPHIC g253489ex99_1p17g1.jpg GRAPHIC 261729
14 GRAPHIC g253489ex99_1p18g1.jpg GRAPHIC 165340
15 GRAPHIC g253489ex99_1p19g1.jpg GRAPHIC 296230
16 GRAPHIC g253489ex99_1p1g1.jpg GRAPHIC 299043
17 GRAPHIC g253489ex99_1p20g1.jpg GRAPHIC 269365
18 GRAPHIC g253489ex99_1p21g1.jpg GRAPHIC 218624
19 GRAPHIC g253489ex99_1p22g1.jpg GRAPHIC 225536
20 GRAPHIC g253489ex99_1p23g1.jpg GRAPHIC 190389
21 GRAPHIC g253489ex99_1p24g1.jpg GRAPHIC 298016
22 GRAPHIC g253489ex99_1p25g1.jpg GRAPHIC 301407
23 GRAPHIC g253489ex99_1p26g1.jpg GRAPHIC 350395
24 GRAPHIC g253489ex99_1p27g1.jpg GRAPHIC 283276
25 GRAPHIC g253489ex99_1p28g1.jpg GRAPHIC 206120
26 GRAPHIC g253489ex99_1p29g1.jpg GRAPHIC 176238
27 GRAPHIC g253489ex99_1p2g1.jpg GRAPHIC 636114
28 GRAPHIC g253489ex99_1p30g1.jpg GRAPHIC 303532
29 GRAPHIC g253489ex99_1p31g1.jpg GRAPHIC 251999
30 GRAPHIC g253489ex99_1p32g1.jpg GRAPHIC 273109
31 GRAPHIC g253489ex99_1p33g1.jpg GRAPHIC 303648
32 GRAPHIC g253489ex99_1p3g1.jpg GRAPHIC 405125
33 GRAPHIC g253489ex99_1p4g1.jpg GRAPHIC 378738
34 GRAPHIC g253489ex99_1p5g1.jpg GRAPHIC 272862
35 GRAPHIC g253489ex99_1p6g1.jpg GRAPHIC 262810
36 GRAPHIC g253489ex99_1p7g1.jpg GRAPHIC 220319
37 GRAPHIC g253489ex99_1p8g1.jpg GRAPHIC 251782
38 GRAPHIC g253489ex99_1p9g1.jpg GRAPHIC 296528
  Complete submission text file 0001193125-22-044450.txt   13055802

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prld-20220216.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20220216_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20220216_pre.xml EX-101.PRE 11255
40 EXTRACTED XBRL INSTANCE DOCUMENT d253489d8k_htm.xml XML 3389
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 22644499
SIC: 2834 Pharmaceutical Preparations